Biohaven (BHVN) Research & Development (2021 - 2026)

Biohaven has disclosed Research & Development across 6 years of filings, most recently posting $103.8 million for Q1 2026.

• Research & Development for Q1 2026 came in at $103.8 million, down 44.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $272.0 million (down 67.13% YoY), and the FY2025 annual result was $635.1 million, down 20.21% from the prior year.
• Research & Development came in at $103.8 million for Q1 2026 at Biohaven, up from $12.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $314.8 million in Q2 2024 to a low of $4.2 million in Q4 2022.
• The 5-year median for Research & Development is $103.8 million (2026), against an average of $113.7 million.
• Across the five-year window, Research & Development jumped 3075.81% in 2023 and tumbled 95.24% in 2025, its largest moves.
• Biohaven's Research & Development stood at $4.2 million in 2022, then surged by 3075.81% to $134.8 million in 2023, then rose by 24.23% to $167.5 million in 2024, then plunged by 92.83% to $12.0 million in 2025, then jumped by 765.22% to $103.8 million in 2026.
• The last three Research & Development figures came in at $103.8 million (Q1 2026), $12.0 million (Q4 2025), and $141.2 million (Q3 2025), per Business Quant data.